Literature DB >> 14662246

A preferred reperfusion strategy for acute myocardial infarction.

Eric J Topol, Franz Josef Neumann, Gilles Montalescot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14662246     DOI： 10.1016/j.jacc.2003.09.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

Review 1.  Management of acute coronary syndromes: an update.

Authors:  Keith A A Fox
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 2.  Should patients with acute ST elevation MI be transferred for primary PCI?

Authors:  S D Kristensen; H R Andersen; L Thuesen; L R Krusell; H E Bøtker; J F Lassen; T T Nielsen
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 3.  Myocardial infarction centres: the way forward.

Authors:  H R Andersen; C J Terkelsen; L Thuesen; L R Krusell; S D Kristensen; H E Bøtker; J F Lassen; T T Nielsen
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

4.  GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: new trial and registry data.

Authors:  Umesh U Tamhane; Hitinder S Gurm
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

5.  Do we need the cardiologist in the prehospital triage for STEMI?

Authors:  F W A Verheugt
Journal:  Neth Heart J       Date:  2005-09       Impact factor: 2.380

6.  Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.

Authors:  Igor Mrdovic; Lidija Savic; Ratko Lasica; Gordana Krljanac; Milika Asanin; Natasa Brdar; Nemanja Djuricic; Jelena Marinkovic; Jovan Perunicic
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-11-21

Review 7.  Current developments in anti-platelet therapy.

Authors:  Florian B Mayr; Bernd Jilma
Journal:  Wien Med Wochenschr       Date:  2006-09

8.  Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice.

Authors:  T Heer; U Zeymer; C Juenger; A K Gitt; H Wienbergen; R Zahn; M Gottwik; J Senges
Journal:  Heart       Date:  2006-04-10       Impact factor: 5.994

9.  Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.

Authors:  Guido Parodi; Giuseppe De Luca; Guia Moschi; Benedetta Bellandi; Renato Valenti; Angela Migliorini; Nazario Carrabba; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.